|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Sialorrhea | |||||
| Cerebral Palsy | |||||
| Neurological Condition | |||||
| Mental Retardation | |||||
| 2 | More general conditions related to this trial | ||||
| Brain Damage, Chronic | |||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Mental Disorders | |||||
| Mental Disorders Diagnosed in Childhood | |||||
| Mouth Diseases | |||||
| Nervous System Diseases | |||||
| Neurobehavioral Manifestations | |||||
| Neurologic Manifestations | |||||
| Salivary Gland Diseases | |||||
| Signs and Symptoms | |||||
| Stomatognathic Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Oral Glycopyrrolate Liquid | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Glycopyrrolate | |||||
| 5 | More general drug interventions related to this trial | ||||
| Adjuvants, Anesthesia | |||||
| Central Nervous System Agents | |||||
| Cholinergic Agents | |||||
| Cholinergic Antagonists | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Muscarinic Antagonists | |||||
| Neurotransmitter Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| ResearchPoint | |||||
| Sciele Pharma | |||||